Medical uses::Progestogen-only pill


Editor::cancer    Breast::pills    Women::-last    -first::journal    Hormonal::title    First::pages

Medical uses The theoretical efficacy is similar to that of the combined oral contraceptive pill (COCP). However, this pill is taken continuously without any breaks between packets, and traditional progestogen-only pills must be taken to a much stricter time every day (within 3 hours vs. a COCP's 12 hours). However, in some countries, the POP Cerazette has an approved window of 12 hours. The effectiveness is, therefore, dependent upon compliance.

Lacking the estrogen of combined pills, they are not associated with increased risks of DVT or heart disease. With the decreased clotting risk, they are not contraindicated in the setting of sickle-cell disease. The progestin-only pill is recommended over regular birth control pills for women who are breastfeeding because the mini-pill does not affect milk production (estrogen reduces the amount of breast milk). Like combined pills, the minipill decreases the likelihood of pelvic inflammatory disease.

It is unclear whether POPs provide protection against ovarian cancer to the extent that COCP do.

There are fewer serious complications than on COCP.<ref>{{#invoke:Citation/CS1|citation |CitationClass=journal }}</ref>

Progestogen-only pill sections
Intro  Medical uses   Side-effects  Mechanism of action  See also  References  

Medical uses
PREVIOUS: IntroNEXT: Medical uses